A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation

We describe a single-center prospective study of alemtuzumab as a second-line agent for steroid-refractory (SR) acute graft-versus-host disease (aGVHD) in pediatric and young adult allogeneic hematopoietic stem cell transplant recipients. Alemtuzumab was administered for grades II to IV aGVHD if pat...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Biol Blood Marrow Transplant
Glavni autori: Khandelwal, Pooja, Emoto, Chie, Fukuda, Tsuyoshi, Vinks, Alexander A., Neumeier, Lisa, Dandoy, Christopher E., El-Bietar, Javier, Chandra, Sharat, Davies, Stella M., Bleesing, Jacob J., Jordan, Michael B., Mehta, Parinda A., Jodele, Sonata, Grimley, Michael S., Kumar, Ashish, Myers, Kasiani C., Marsh, Rebecca A.
Format: Artigo
Jezik:Inglês
Izdano: 2016
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5683393/
https://ncbi.nlm.nih.gov/pubmed/27664325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2016.09.016
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items